TSN

Translin · Q15631 · TSN on Sugi Atlas →

0 patent compounds predicted against TSN, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TSN by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian Cancer PHASE2UNKNOWN
Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders. PHASE1/PHASE2RECRUITING
Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety PHASE2COMPLETED
I/II Phase Study Evaluating M1774 in Combination With Fulvestrant in HR+ and HER2- Advanced Breast Cancers PHASE1/PHASE2NOT_YET_RECRUITING
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients PHASE2COMPLETED
Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer PHASE2COMPLETED
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer PHASE1/PHASE2COMPLETED
Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer PHASE2COMPLETED
Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma PHASE1WITHDRAWN
Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer nanUNKNOWN
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
Improvement of DIAgnostic and Phenotype-genotype Correlation Studies in Patients With MYOpathy Suspected of TITinopathy nanUNKNOWN
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Nasal Brushing for the Diagnosis and Understanding of Telomeropathies nanUNKNOWN
Telomere Repair Gene Mutation in Inflammatory Bowel Disease nanCOMPLETED
Effect of Diaphragm Stimulation During Surgery nanCOMPLETED
Telomeres Length in Israeli Fibrotic ILD Patients nanENROLLING_BY_INVITATION
Spironolactone and XPB-1 Integrity in the TFIIH Complex nanENROLLING_BY_INVITATION
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
Skeletal Muscle Inflammation, Oxidative Stress and DNA Repair in Age-Related Sarcopenia nanCOMPLETED
Mitochondrial DNA Copy Number and Leukocyte Telomere Length as Biomarkers in Type 2 Diabetic Patients nanUNKNOWN
Maximizing Mechanisms of Muscle Hypertrophy to Combat Sarcopenia in Older Adults nanCOMPLETED
Biological Aging Hallmarks-Guided Integrative TCM and Conventional Medicine in Post-Treatment Unexplained Female Infertility nanRECRUITING
Telomere Disclosure and Impact on Psychological Distress and Health Behaviors nanCOMPLETED
TS Overexpression in SCLC: Mechanism and Therapeutic Targeting nanCOMPLETED
Body Awareness and Aerobic Exercise: Telomere Impact nanCOMPLETED
Rapamycin as a Means of Interference With Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory nanCOMPLETED
The Effects of Whey vs. Collagen on MPS nanCOMPLETED
miRNA as a Growth Plate Marker After GH nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a TSN binder may also engage these)

ProteinNameSimilarity
Q62348 1.000 Q62348 →
P97891 1.000 P97891 →
Q08DM8 1.000 Q08DM8 →
Q5R7P2 1.000 Q5R7P2 →
P79769 0.993 P79769 →
A4GWN3 0.962 A4GWN3 →
Q9QZE7 0.961 Q9QZE7 →
O35841 0.961 O35841 →
Q5ZMW3 0.960 Q5ZMW3 →
Q5R644 0.960 Q5R644 →
A1Z3X3 0.960 A1Z3X3 →
A0MT11 0.959 A0MT11 →
Q5RC21 0.958 Q5RC21 →
Q9JHB5 0.958 Q9JHB5 →
Q6P1I3 0.958 Q6P1I3 →
A4QNE0 0.958 A4QNE0 →
Q56A27 0.958 Q56A27 →
Q5ZJZ6 0.957 Q5ZJZ6 →
TSNAX Translin-associated protein X 0.957 landscape →
Q63616 0.956 Q63616 →
Q8IWV8 0.956 Q8IWV8 →
Q5ZKG8 0.956 Q5ZKG8 →
Q80YQ8 0.956 Q80YQ8 →
API5 Apoptosis inhibitor 5 0.956 landscape →
Q5U3V9 0.955 Q5U3V9 →
BZW2 eIF5-mimic protein 1 0.955 landscape →
Q6GLK9 0.955 Q6GLK9 →
P23116 0.955 P23116 →
Q5E9L7 0.955 Q5E9L7 →
Q9H871 0.955 Q9H871 →